It was reported that on (b)(6) 2023, the patient underwent right eye cataract extraction during which an intraocular lens (iol) was implanted.Re-examination on surgery day showed visual acuity of 0.5 in the right eye, mild conjunctival congestion, mild corneal edema.On (b)(6) 2023, the patient complained of pain and discomfort.The visual acuity of the right eye was 0.3, conjunctival congestion, corneal edema, inflammatory exudation in the anterior chamber, large inflammatory exudation on the lens surface, and no significant abnormality in the fundus after mydriasis.Intraocular pressure was 9.0 mmhg.The following has been prescribed: prednisolone acetate eye drops 5 ml/vial 0.02 ml was applied to the right eye once a hour, levofloxacin eye drops 0.02 ml was applied to the right eye once a hour, tobramycin dexamethasone eye ointment was applied to the right eye once a night, atropine sulfate eye gel was applied to the right eye 3 times a day, sodium chloride injection 250 ml, dexamethasone sodium squamous solution injection 2 ml and ceftazidime for injection 3 g were intravenously infused once a day for treatment.No further information was provided.
|
Weight and ethnicity: unknown/ not provided.Patient information cannot be provided due to personal data privacy legislation/policy.Explant date: explant date: not applicable, as lens remains implanted.Email address: unknown/not provided, as information was asked but not provided.Initial reporter telephone number: (b)(6).Device evaluated by mfr: the device is not returning for evaluation as it remains implanted; therefore, a failure analysis of the complaint device cannot be completed.A review of the device history record, complaint trending, and risk documentation for this device will be performed.Upon completion of the review, if there is any further relevant information a supplemental medwatch will be filed.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
|